Why subscribe?

Subscribe to get full access to the newsletter and publication archives.

Stay up-to-date

Never miss an update—every new post is sent directly to your email inbox. For a spam-free, ad-free reading experience, plus audio and community features, get the Substack app.

Join the crew

Be part of a community of people who share your interests. Participate in the comments section, or support this work with a subscription.

To learn more about the tech platform that powers this publication, visit Substack.com.

User's avatar

Subscribe to Forever.AI: AI, Robotics, Quantum, Longevity, Cryonics & BCI

Dedicated to extending healthy productive life for everyone on the planet. Covers advances in longevity, AI, robotics, cryonics, quantum, and other emerging technologies. Posts are strictly personal, not reflective of positions of Insilico Medicine.

People

Alex Zhavoronkov, PhD, is CEO of Insilico Medicine, a generative AI biotech, which raised $500mil, nominated 22 preclinical candidates and got into clinical trials. He's also an adjunct professor at the Buck Institute for Aging.